Standardized terminology and nomenclature for pancreatobiliary cytology: The Papanicolaou Society of Cytopathology guidelines

Diagnostic Cytopathology

Volumn 42, Issue 4, 2014, Pages 338-350

  Pitman, Martha B ^a   Centeno, Barbara A ^b   Ali, Syed Z ^c   Genevay, Muriel ^d   Stelow, Ed ^e   Mino Kenudson, Mari ^a   Fernandez Del Castillo, Carlos ^a   Max Schmidt, C ^f   Brugge, William ^a   Layfield, Lester ^g  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^e UNIVERSITY OF VIRGINIA MEDICAL CENTER   (United States)

^f INDIANA UNIVERSITY MEDICAL CENTER   (United States)

^g University of Missouri   (United States)

Author keywords

guidelines; nomenclature; pancreas; PSC; terminology

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; K RAS PROTEIN; MUCIN;

ACINAR CELL CARCINOMA; ADENOSQUAMOUS CARCINOMA; ARTICLE; BILE DUCT CARCINOMA; BILE DUCT CYST; BILIARY INTRAEPITHELIAL NEOPLASIA; CANCER DIAGNOSIS; CANCER GRADING; CELL PROLIFERATION; CYST FLUID; CYSTADENOMA; CYTOLOGY; DIGESTIVE SYSTEM DISEASE; ENDOSCOPIC ULTRASOUND GUIDED FINE NEEDLE BIOPSY; ENTEROENDOCRINE CELL; FALSE NEGATIVE RESULT; HOSPITAL INFORMATION SYSTEM; HUMAN; INTRADUCTAL PAPILLARY MUCINOUS TUMOR; KIDNEY CARCINOMA; LARGE CELL NEUROENDOCRINE CARCINOMA; LYMPHOMA; MEDICAL SOCIETY; MEDULLARY CARCINOMA; METASTASIS; MUCINOUS CYSTIC NEOPLASM; NEUROENDOCRINE TUMOR; NOMENCLATURE; PANCREAS ADENOCARCINOMA; PANCREAS CARCINOMA; PANCREATOBILIARY CYTOLOGY; PANCREATOBILIARY DISEASE; PANCREATOBLASTOMA; PRACTICE GUIDELINE; PREMALIGNANT MUCINOUS CYST; PRIORITY JOURNAL; SMALL CELL CARCINOMA; SOLID PSEUDOPAPILLARY TUMOR; UNDIFFERENTIATED CARCINOMA;

GUIDELINES; NOMENCLATURE; PANCREAS; PSC; TERMINOLOGY;

BILE DUCT NEOPLASMS; BILIARY TRACT; CYTODIAGNOSIS; HUMANS; PANCREAS; PANCREATIC NEOPLASMS; REFERENCE STANDARDS; SOCIETIES, MEDICAL; TERMINOLOGY AS TOPIC;

EID: 84896397072     PISSN: 87551039     EISSN: 10970339     Source Type: Journal    
DOI: 10.1002/dc.23092     Document Type: Article

References (87)

1. Tanaka M, Chari S, Adsay V, et al. International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas. Pancreatology 2006; 6 (1-2): 17-32.
2. Tanaka M, Fernández-del Castillo C, Adsay V, et al. International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas. Pancreatology 2012; 12 (3): 183-197.
3. Brugge WR, Lewandrowski K, Lee-Lewandrowski E,. Diagnosis of pancreatic cystic neoplasms: A report of the cooperative pancreatic cyst study. Gastroenterology 2004; 126 (5): 1330-1336.
4. Cizginer S, Turner BG, Bilge AR, Karaca C, Pitman MB, Brugge WR,. Cyst fluid carcinoembryonic antigen is an accurate diagnostic marker of pancreatic mucinous cysts. Pancreas 2011; 40 (7): 1024-1028.
5. van der Waaij LA, van Dullemen HM, Porte RJ,. Cyst fluid analysis in the differential diagnosis of pancreatic cystic lesions: A pooled analysis. Gastrointest Endosc 2005; 62 (3): 383-389.
6. Turner BG, Cizginer S, Agarwal D, Yang J, Pitman MB, Brugge WR,. Diagnosis of pancreatic neoplasia with EUS and FNA: A report of accuracy. Gastrointest Endosc 2010; 71 (1): 91-98.
7. Ylagan LR, Edmundowicz S, Kasal K, Walsh D, Lu DW,. Endoscopic ultrasound guided fine-needle aspiration cytology of pancreatic carcinoma: A 3-year experience and review of the literature. Cancer 2002; 96 (6): 362-369.
8. Frossard JL, Amouyal P, Amouyal G, et al. Performance of endosonography-guided fine needle aspiration and biopsy in the diagnosis of pancreatic cystic lesions. Am J Gastroenterol 2003; 98 (7): 1516-1524.
9. Wu R, Yoon WJ, Brugge WR, Mino-Kenudson M, Pitman MB,. Endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) contributes to a triple negative test in preoperative screening of pancreatic cysts. Cancer Cytopathol. 2013 Dec 10. doi: 10.1002/cncy.21385. [Epub ahead of print].
10. Volmar KE, Vollmer RT, Routbort MJ, Creager AJ,. Pancreatic and bile duct brushing cytology in 1000 cases: Review of findings and comparison of preparation methods. Cancer 2006; 108 (4): 231-238.
11. Layfield LJ, Hirschowitz SR, Olson M, Syed A, Dodd L,. Significance of the diagnostic categories "atypical" and "suspicious for malignancy" in the cytologic diagnosis of solid pancreatic masses. Diagn Cytopath. In press.
12. Pitman MB, Centeno BA, Daglilar ES, Brugge WR, Mino-Kenudson M,. Cytological criteria of high-grade epithelial atypia in the cyst fluid of pancreatic intraductal papillary mucinous neoplasms. Cancer (Cancer Cythopathol). 2014;122(1):40-47.
13. Pitman MB, Yaeger KA, Brugge WR, Mino-Kenudson M,. Prospective analysis of atypical epithelial cells as a high-risk cytologic feature for malignancy in pancreatic cysts. Cancer Cytopathol 2013; 121 (1): 29-36.
14. Jarboe EA, Layfield LJ,. Cytologic features of pancreatic intraepithelial neoplasia and pancreatitis: Potential pitfalls in the diagnosis of pancreatic ductal carcinoma. Diagn Cytopathol 2011; 39 (8): 575-581.
15. Nagle J, Wilbur DC, Pitman MD,. The cytomorphology of gastric and duodenal epithelium and reactivity to B72.3: A baseline for comparison to pancreatic neoplasms aspirated by EUS-FNAB. Diagn Cytopathol 2005; 33: 381-386.
16. Zen Y, Adsay NV, Bardadin K, et al. Biliary intraepithelial neoplasia: An international interobserver agreement study and proposal for diagnostic criteria. Mod Pathol 2007; 20 (6): 701-709.
17. Lee JG, Leung JW, Baillie J, Layfield LJ, Cotton PB,. Benign, dysplastic, or malignant-making sense of endoscopic bile duct brush cytology: Results in 149 consecutive patients. Am J Gastroenterol 1995; 90 (5): 722-726.
18. Belsley NA, Pitman MB, Lauwers GY, Brugge WR, Deshpande V,. Serous cystadenoma of the pancreas: Limitations and pitfalls of endoscopic ultrasound-guided fine-needle aspiration biopsy. Cancer 2008; 114 (2): 102-110.
19. Ferrone CR, Tang LH, Tomlinson J, et al. Determining prognosis in patients with pancreatic endocrine neoplasms: Can the WHO classification system be simplified? J Clin Oncol 2007; 25 (35): 5609-5615.
20. Kuo EJ, Salem RR,. Population-level analysis of pancreatic neuroendocrine tumors 2 cm or less in size. Ann Surg Oncol 2013; 20 (9): 2815-2821.
21. Haynes AB, Deshpande V, Ingkakul T, et al. Implications of incidentally discovered, nonfunctioning pancreatic endocrine tumors: Short-term and long-term patient outcomes. Arch Surg 2011; 146 (5): 534-538.
22. Klimstra DS, Capella C, Hruban RH, Arnold R, Kloppel G., Neuroendocrine neoplasms of the pancreas. In:, Carneiro F, Bosman C, Hruban RH, Theise ND, editors. WHO classification of tumours of the digestive system. 4th ed. Lyon: Stylus Publishing, LLC; 2010.
23. Klimstra DS,. Pathology reporting of neuroendocrine tumors: Essential elements for accurate diagnosis, classification, and staging. Semin Oncol 2013; 40 (1): 23-36.
24. Kloppel G, Klimstra DS, Maitra A, et al. In:, Carneiro F, Bosman C, Hruban RH, Theise ND, editors. Solid-pseudopapillary neoplasm of the pancreas. Sterling: Stylus Publishing, LLC; 2010. p 327-330.
25. Crippa S, Fernández-Del Castillo C, Salvia R, et al. Mucin-producing neoplasms of the pancreas: An analysis of distinguishing clinical and epidemiologic characteristics. Clin Gastroenterol Hepatol 2010; 8 (2): 213-219.
26. Crippa S, Salvia R, Warshaw AL, et al. Mucinous cystic neoplasm of the pancreas is not an aggressive entity: Lessons from 163 resected patients. Ann Surg 2008; 247 (4): 571-579.
27. Hruban RH, Pitman MB, Klimstra DS,. Tumors of the pancreas. Atlas of tumor pathology, 4th series, fascicle 6. Washington, DC: American Registry of Pathology; Armed Forces Institutes of Pathology; 2007.
28. Pitman MB, Deshpande V,. Endoscopic ultrasound-guided fine needle aspiration cytology of the pancreas: A morphological and multimodal approach to the diagnosis of solid and cystic mass lesions. Cytopathology 2007; 18 (6): 331-347.
29. Pitman MB, Michaels PJ, Deshpande V, Brugge WR, Bounds BC,. Cytological and cyst fluid analysis of small (< or =3 cm) branch duct intraductal papillary mucinous neoplasms adds value to patient management decisions. Pancreatology 2008; 8 (3): 277-284.
30. Pitman MB, Genevay M, Yaeger K, et al. High-grade atypical epithelial cells in pancreatic mucinous cysts are a more accurate predictor of malignancy than "positive" cytology. Cancer Cytopathol 2010; 118: 434-440.
31. Adsay NV,. Cystic neoplasia of the pancreas: Pathology and biology. J Gastrointest Surg 2008; 12 (3): 401-404.
32. Adsay NV, Longnecker DS, Klimstra DS,. Pancreatic tumors with cystic dilatation of the ducts: Intraductal papillary mucinous neoplasms and intraductal oncocytic papillary neoplasms. Semin Diagn Pathol 2000; 17: 16-31.
33. Adsay NV, Merati K, Basturk O, et al. Pathologically and biologically distinct types of epithelium in intraductal papillary mucinous neoplasms: Delineation of an "intestinal" pathway of carcinogenesis in the pancreas. Am J Surg Pathol 2004; 28 (7): 839-848.
34. Hruban RH, Takaori K, Klimstra DS, et al. An illustrated consensus on the classification of pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasms. Am J Surg Pathol 2004; 28 (8): 977-987.
35. Adsay NV, Pierson C, Sarkar F, et al. Colloid (mucinous noncystic) carcinoma of the pancreas. Am J Surg Pathol 2001; 25 (1): 26-42.
36. Mino-Kenudson M, Fernández-del Castillo C, Baba Y, et al. Prognosis of invasive intraductal papillary mucinous neoplasm depends on histological and precursor epithelial subtypes. Gut 2011; 60 (12): 1712-1720.
37. Moparty B, Pitman MB, Brugge WR,. Pancreatic cyst fluid amylase is not a marker to differentiate IPMN from MCN. Gastrointest Endosc 2007; 65 (5): AB303.
38. Kucera S, Centeno BA, Springett G, et al. Cyst fluid carcinoembryonic antigen level is not predictive of invasive cancer in patients with intraductal papillary mucinous neoplasm of the pancreas. JOP 2012; 13 (4): 409-413.
39. Ryu JK, Woo SM, Hwang JH, et al. Cyst fluid analysis for the differential diagnosis of pancreatic cysts. Diagn Cytopathol 2004; 31 (2): 100-105.
40. O'Toole D, Palazzo L, Hammel P, et al. Macrocystic pancreatic cystadenoma: The role of EUS and cyst fluid analysis in distinguishing mucinous and serous lesions. Gastrointest Endosc 2004; 59 (7): 823-829.
41. Khalid A, Zahid M, Finkelstein SD, et al. Pancreatic cyst fluid DNA analysis in evaluating pancreatic cysts: A report of the PANDA study. Gastrointest Endosc 2009; 69 (6): 1095-1102.
42. Shen J, Brugge WR, Dimaio CJ, Pitman MB,. Molecular analysis of pancreatic cyst fluid: A comparative analysis with current practice of diagnosis. Cancer Cytopathol 2009; 117 (3): 217-227.
43. Wu J, Matthaei H, Maitra A, et al. Recurrent GNAS mutations define an unexpected pathway for pancreatic cyst development. Sci Transl Med 2011; 3 (92): 92ra66.
44. Lau SK, Lewandrowski KB, Brugge WR, Warshaw A, and, Centeno BA,. Diagnostic significance of mucin in fine needle aspiration samples of pancreatic cysts. Mod Pathol 2000; 13 (3): 48A.
45. Pitman MB, Centeno BA, Genevay M, Fonseca R, Mino-Kenudson M,. Grading epithelial atypia in EUS-FNA of intraductal papillary mucinous neoplasms: An International Interobserver Concordance study. Cancer (Cancer Cythopathol) 2013; 121 (12): 729-36.
46. Genevay M, Mino-Kenudson M, Yaeger K, et al. Cytology adds value to imaging studies for risk assessment of malignancy in pancreatic mucinous cysts. Ann Surg 2011; 254 (6): 977-983.
47. Pitman M, Centeno BA, Genevay M, Fonseca R, Mino-Kenudson M,. Grading epithelial atypia in EUS-FNA of pancreatic mucinous cysts: An international interobsever concordance study. J Am Soc Cytopathol 2012; 1: 178; S99.
48. Pitman MB,. Pancreatic cyst fluid triage: A critical component of the preoperative evaluation of pancreatic cysts. Cancer Cytopathol 2013; 121 (2): 57-60.
49. Layfield LJ, Cramer H,. Fine-needle aspiration cytology of intraductal papillary-mucinous tumors: A retrospective analysis. Diagn Cytopathol 2005; 32 (1): 16-20.
50. Kloek JJ, van der Gaag NA, Erdogan D, et al. A comparative study of intraductal papillary neoplasia of the biliary tract and pancreas. Hum Pathol 2011; 42 (6): 824-832.
51. Barton JG, Barrett DA, Maricevich MA, et al. Intraductal papillary mucinous neoplasm of the biliary tract: A real disease? HPB (Oxford) 2009; 11 (8): 684-691.
52. Ando N, Goto H, Niwa Y, et al. The diagnosis of GI stromal tumors with EUS-guided fine needle aspiration with immunohistochemical analysis. Gastrointest Endosc 2002; 55 (1): 37-43.
53. Reith JD, Goldblum JR, Lyles RH, Weiss SW,. Extragastrointestinal (soft tissue) stromal tumors: An analysis of 48 cases with emphasis on histologic predictors of outcome. Mod Pathol 2000; 13 (5): 577-585.
54. Willmore-Payne C, Layfield LJ, Holden JA,. c-KIT mutation analysis for diagnosis of gastrointestinal stromal tumors in fine needle aspiration specimens. Cancer 2005; 105 (3): 165-170.
55. Barr Fritcher EG, Caudill JL, Blue JE, et al. Identification of malignant cytologic criteria in pancreatobiliary brushings with corresponding positive fluorescence in situ hybridization results. Am J Clin Pathol 2011; 136 (3): 442-449.
56. Eloubeidi MA, Jhala D, Chhieng DC, et al. Yield of endoscopic ultrasound-guided fine-needle aspiration biopsy in patients with suspected pancreatic carcinoma. Cancer 2003; 99 (5): 285-292.
57. Bhutani MS, Hawes RH, Baron PL, et al. Endoscopic ultrasound guided fine needle aspiration of malignant pancreatic. Endoscopy 1997; 29 (9): 854-858.
58. Faigel DO, Ginsberg GG, Bentz JS, et al. Endoscopic ultrasound-guided real-time fine-needle aspiration biopsy of the pancreas in cancer patients with pancreatic lesions. J Clin Oncol 1997; 15 (4): 1439-1443.
59. Lin F, Staerkel GA,. Cytologic criteria for well differentiated adenocarcinoma of the pancreas in fine-needle aspiration biopsy specimens. Cancer 2003; 99 (1): 44-50.
60. Layfield LJ, Dodd L, Factor R, Schmidt RL,. Malignancy risk associated with diagnostic categories defined by the Papanicolaou Society of Cytopathology pancreatico biliary guidelines. Diagn Cytopath. In press.
61. Layfield LJ, Wax TD, Lee JG, Cotton PB,. Accuracy and morphologic aspects of pancreatic and biliary duct brushings. Acta Cytol 1995; 39: 11-18.
62. Ylagan LR, Liu LH, Maluf HM,. Endoscopic bile duct brushing of malignant pancreatic biliary strictures: Retrospective study with comparison of conventional smear and ThinPrep techniques. Diagn Cytopathol 2003; 28 (4): 196-204.
63. Eloubeidi M, Chen VK, Eltoum IA, et al. Endoscopic ultrasound-guided fine needle aspiration biopsy of patients with suspected pancreatic cancer: Diagnostic accuracy and acute and 30-day complications. Am J Gastroenterol 2003; 98: 2663-2668.
64. Eloubeidi MA, Tamhane A,. EUS-guided FNA of solid pancreatic masses: A learning curve with 300 consecutive procedures. Gastrointest Endosc 2005; 61 (6): 700-708.
65. Adamsen S, Olsen M, Jendresen MB, Holck S, Glenthøj A,. Endobiliary brush biopsy: Intra- and interobserver variation in cytological evaluation of brushings from bile duct strictures. Scand J Gastroenterol 2006; 41 (5): 597-603.
66. Hebert-Magee S, Bae S, Varadarajulu S, et al. The presence of a cytopathologist increases the diagnostic accuracy of endoscopic ultrasound-guided fine needle aspiration cytology for pancreatic adenocarcinoma: A meta-analysis. Cytopathology 2013; 24 (3): 159-171.
67. Klapman JB, Logrono R, Dye CE, Waxman I,. Clinical impact of on-site cytopathology interpretation on endoscopic ultrasound-guided fine needle aspiration. Am J Gastroenterol 2003; 98 (6): 1289-1294.
68. da Cunha Santos G, Ko HM, Saieg MA, Geddie WR,. "The petals and thorns" of ROSE (rapid on-site evaluation). Cancer Cytopathol 2013; 121 (1): 4-8.
69. Cohen MB, Wittchow RJ, Johlin FC, Bottles K, Raab SS,. Brush cytology of the extrahepatic biliary tract: Comparison of cytologic features of adenocarcinoma and benign biliary strictures. Mod Pathol 1995; 8: 498-502.
70. Nakajima T, Tajima Y, Sugano I, et al. Multivariate statistical analysis of bile cytology. Acta Cytol 1994; 38 (1): 51-55.
71. Renshaw AA, Madge R, Jiroutek M, Granter SR,. Bile duct brushing cytology. Statistical analysis of proposed diagnostic criteria. Am J Clin Pathol 1998; 110: 635-640.
72. Kipp BR, Stadheim LM, Halling SA, et al. A comparison of routine cytology and fluorescence in situ hybridization for the detection of malignant bile duct strictures. Am J Gastroenterol 2004; 99 (9): 1675-1681.
73. Layfield LJ, Cramer H,. Primary sclerosing cholangitis as a cause of false positive bile duct brushing cytology: Report of two cases. Diagn Cytopathol 2005; 32 (2): 119-124.
74. Rahemtullah A, Misdraji J, Pitman MB,. Adenosquamous carcinoma of the pancreas: Cytologic features in 14 cases. Cancer 2003; 99 (6): 372-378.
75. Chopra S, Wu ML, Imagawa DK, Lee J, Gu M,. Endoscopic ultrasound-guided fine-needle aspiration of undifferentiated carcinoma with osteoclast-like giant cells of the pancreas: A report of 2 cases with literature review. Diagn Cytopathol 2007; 35 (9): 601-606.
76. Paal E, Thompson LD, Frommelt RA, Przygodzki RM, Heffess CS,. A clinicopathologic and immunohistochemical study of 35 anaplastic carcinomas of the pancreas with a review of the literature. Ann Diag Pathol 2001; 5 (3): 129-140.
77. Kitagami H, Kondo S, Hirano S, Kawakami H, Egawa S, Tanaka M,. Acinar cell carcinoma of the pancreas: Clinical analysis of 115 patients from Pancreatic Cancer Registry of Japan Pancreas Society. Pancreas 2007; 35 (1): 42-46.
78. Hartwig W, Denneberg M, Bergmann F, et al. Acinar cell carcinoma of the pancreas: Is resection justified even in limited metastatic disease? Am J Surg 2011; 202 (1): 23-27.
79. Suzuki A, Sakaguchi T, Morita Y, et al. Long-term survival after a repetitive surgical approach in a patient with acinar cell carcinoma of the pancreas and recurrent liver metastases: Report of a case. Surg Today 2010; 40 (7): 679-683.
80. Matos JM, Schmidt CM, Turrini O, et al. Pancreatic acinar cell carcinoma: A multi-institutional study. J Gastrointest Surg 2009; 13 (8): 1495-1502.
81. Schmidt CM, Matos JM, Bentrem DJ, Talamonti MS, Lillemoe KD, Bilimoria KY,. Acinar cell carcinoma of the pancreas in the United States: Prognostic factors and comparison to ductal adenocarcinoma. J Gastrointest Surg 2008; 12 (12): 2078-2086.
82. Seth AK, Argani P, Campbell KA, et al. Acinar cell carcinoma of the pancreas: An institutional series of resected patients and review of the current literature. J Gastrointest Surg 2008; 12 (6): 1061-1067.
83. Basturk O, Zamboni G, Klimstra DS, et al. Intraductal and papillary variants of acinar cell carcinomas: A new addition to the challenging differential diagnosis of intraductal neoplasms. Am J Surg Pathol 2007; 31 (3): 363-370.
84. Yachida S, Vakiani E, White CM, et al. Small cell and large cell neuroendocrine carcinomas of the pancreas are genetically similar and distinct from well-differentiated pancreatic neuroendocrine tumors. Am J Surgical Pathol 2012; 36 (2): 173-184.
85. Morohoshi T, Klimstra DS, Ohike N, Terris B, Pancreatoblastoma. In:, Carneiro F, Bosman C, Hruban RH, Theise ND, editors. WHO classification of tumours of the digestive system. Lyon: International Agency for Research on Cancer; 2010. p 319-321.
86. Volmar KE, Routbort MJ, Jones CK, Xie HB,. Primary pancreatic lymphoma evaluated by fine-needle aspiration: Findings in 14 cases. Am J Clin Pathol 2004; 121: 898-903.
87. Thompson LD, Heffess CS,. Renal cell carcinoma to the pancreas in surgical pathology material. Cancer 2000; 89 (5): 1076-1088.